Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases
Carolin Landt, Friederike Held, Konstantina Kolotourou, Mihaela Guranda et autres
BACKGROUND AND OBJECTIVES: Complement-targeting therapies are pivotal in managing neuromyelitis optica spectrum disorder (NMOSD), calling for a deeper understanding of complement activation across idiopathic inflammatory demyelinating diseases (IIDDs) of the CNS. C4d, a covalently bound complement split product, offers prolonged detectability at …
de, gr, at (code pays fourni par la source)